文献速递肿瘤 PET/CT核素与放射性配体治疗

68Ga-PSMA-11 PET/MRI 在低 PSA 值≤0.5 ng/mL 前列腺癌复发中的检出率与定位

Detection Rate and Localization of Prostate Cancer Recurrence Using 68Ga-PSMA-11 PET/MRI in Patients with Low PSA Values ≤ 0.5 ng/mL.
PubMed 文献 · J Nucl Med · 2019-08-02

该回顾性研究纳入 66 例生化复发且 PSA≤0.5 ng/mL 的患者,行 68Ga-PSMA-11 PET/MRI 检查。总体 PSMA 阳性病灶检出率为 54.5%;PSA 0.2–0.5 ng/mL 组为 65%,PSA<0.2 ng/mL 组为 38.5%。39.4% 患者的 PSMA 阳性病灶位于标准挽救性放疗体积之外。

要点

  • PSA≤0.5 ng/mL 时 68Ga-PSMA-11 PET/MRI 总检出率为 54.5%。
  • PSA 0.2–0.5 ng/mL 组检出率 65%,PSA<0.2 ng/mL 组为 38.5%。
  • 39.4% 患者的 PSMA 阳性病灶位于标准挽救性放疗体积外。

核心结论

  • 68Ga-PSMA-11 PET/MRI 在 PSA≤0.5 ng/mL 的复发性前列腺癌中仍具有高检出率。
  • 39.4% 患者的 PSMA 阳性病灶位于标准挽救性放疗体积之外。

研究设计与样本

  • 回顾性分析 66 例连续接受 68Ga-PSMA-11 PET/MRI 检查的生化复发且 PSA≤0.5 ng/mL 患者。
  • 中位 PSA 为 0.23 ng/mL(范围 0.03–0.5 ng/mL)。

主要发现

  • 66 例中 36 例(54.5%)检出 PSMA 阳性病灶。
  • PSA 0.2–0.5 ng/mL 的 40 例中 26 例(65%)检出,PSA<0.2 ng/mL 的 26 例中 10 例(38.5%)检出。
  • 仅 8/66(12.1%)为单纯局部复发;23 例检出淋巴结,5 例检出骨转移。
  • 26/66(39.4%)患者的 PSMA 阳性病灶位于标准挽救性放疗体积之外。

临床怎么用

  • 对于 PSA≤0.5 ng/mL 的生化复发患者,可考虑行 68Ga-PSMA-11 PET/MRI 以定位病灶。
  • PET/MRI 结果可提示病灶是否位于标准挽救性放疗体积之外,辅助放疗靶区规划。

局限性

  • 为单中心回顾性分析,样本量 66 例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A first analysis of simultaneous 68Ga-prostate-specific membrane antigen (PSMA)-11 PET/MRI showed some improvement in the detection of recurrent disease at low serum prostate specific antigen (PSA) values below 0.5 ng/mL compared with the already high detection rate of 68Ga-PSMA-11 PET/CT. We therefore focused on all patients with biochemical recurrence and PSA values no higher than 0.5 ng/mL to assess the detection rate for 68Ga-PSMA-11 PET/MRI. Methods: We retrospectively analyzed a cohort of 66 consecutive patients who underwent 68Ga-PSMA-11 PET/MRI for biochemical recurrence with a PSA value no higher than 0.5 ng/mL at our institution. Median PSA level was 0.23 ng/mL (range, 0.03-0.5 ng/mL). Detection of PSMA-positive lesions within the prostate fossa, local and distant lymph nodes, bones, or visceral organs was recorded. In addition, all scans with 68Ga-PSMA-11 PET/MRI-positive lesions were retrospectively assessed to analyze if lesions were detected inside or outside a standard salvage radiotherapy volume. Results: Overall, in 36 of 66 patients (54.5%) PSMA-positive lesions were detected; in 26 of 40 (65%) patients with a PSA level between 0.2 and 0.5 ng/mL and in 10 of 26 (38.5%) patients with a PSA level less than 0.2 ng/mL. Even at those low PSA values, only 8 of 66 (12.1%) patients had exclusive local recurrence. Lymph nodes were detected in 23 patients and bone metastases in 5 on 68Ga-PSMA-11 PET/MRI. In 26 of 66 patients (39.4%), PSMA-positive lesions were located outside a standard salvage radiotherapy volume. Conclusion: Our data confirm that 68Ga-PSMA-11 PET/MRI has a high detection rate for recurrent prostate cancer, even at low PSA levels no higher than 0.5 ng/mL. In addition, we show that 68Ga-PSMA-11 PET/MRI detected PSMA-positive lesions outside a standard salvage radiotherapy volume in 39.4% of all patients.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Kranzbühler B, Müller J, Becker AS, et al. Detection Rate and Localization of Prostate Cancer Recurrence Using 68Ga-PSMA-11 PET/MRI in Patients with Low PSA Values ≤ 0.5 ng/mL. J Nucl Med. 2019. PMID: 31375566. doi:10.2967/jnumed.118.225276

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。